News

Prostate cancer is claimed to be the most frequently occurring cancer among males in developed countries and accounts for 9% of cancer deaths in men, second only to

Following a recent meeting with the Therapeutic Products Directorate (TPD) of Health Canada, and after the receipt of the positive decision on eligibility, Santhera now has 60 days

More than two-thirds of the total shares outstanding and entitled to vote at the shareholders' meeting were voted in favor of the transaction. In accordance with the terms

Massachusetts-based diagnostics products manufacturer Inverness completed the acquisition through the merger of a wholly-owned subsidiary with and into Cholestech, after Cholestech's shareholders approved the deal. Ron Zwanziger, chairman,

Dr Lesley Russell, executive vice president of worldwide medical and regulatory operations, said: “This is our first regulatory filing for Treanda and a significant milestone for our growing

The Court of Appeals for the Federal Circuit ruled that the New Jersey federal district court should not have granted summary judgment to the generic manufacturers, and that

According to Pfizer, grants will be awarded for research focusing on fostering a clearer understanding of cardiovascular risk-reduction strategies, such as educational programs, risk-assessment tools, screenings and clinical

According to the company, the committee's positive opinion for Vectibix is based on a positive benefit and risk assessment in a patient population that currently has few treatment

Bionovo expects to grant its underwriters a 30-day option to purchase up to 1.71 million shares at the public offering price to cover over-allotments, if any. BMO Capital